Advance Your Avian Influenza Research with Precision, Speed, and Confidence
Trusted Viral Stocks and Assay Services for Diagnostic and Vaccine Development
Facing the growing threat of Avian Influenza requires reliable partners and precise solutions. Microbiologics supports researchers and developers advancing diagnostics and vaccines for both animal and human health with a comprehensive portfolio of services. We offer ready-to-ship and custom-made viral stocks for both low-pathogenic and high-pathogenic Avian Influenza strains, enabling you to move quickly from research to application. For development and validation needs, our CRO laboratory testing and assay development services deliver dependable data to accelerate your programs forward.
Accelerate Avian Influenza Research with Trusted Viral Stocks and CRO Laboratory Services
Flexible, Expert Support for Diagnostic and Vaccine Developers
From early-stage discovery through regulatory submission, Microbiologics offers flexible, end-to-end support tailored to your development pipeline. Whether you require a ready-to-go panel of influenza strains for assay validation, a customized virus to model emerging outbreaks, or reliable CRO testing services to generate precise, reproducible data, we have the expertise and infrastructure to help you succeed.
Our scientists are highly experienced in supporting diagnostic assay developers and vaccine researchers across both animal and human health initiatives. We understand your need for fast turnarounds, reliable quality, and data that meet rigorous standards — and we deliver.
Featured Avian Influenza Solutions
Reassortant LPAI H5N1 (Clade 2.3.4.4b)
- HPAI H5 HA polybasic site removed (converted to LPAI)
- BSL-2 material — no Select Agent or BSL-3 requirements
- Live or Inactivated formats for diagnostic and assay R&D
MS-2 Phage Protected HPAI H5N1 RNA (pRNA)
- HA gene segment (A/Texas/37/2024) encapsidated in MS-2 phage
- BSL-1 molecular assay target control
Custom BSL-3 Assay Services for HPAI & LPAI H5N1 and H7N9
- Historic and current strains
- Tailored assay development and validation
- Supported by our BSL-3 lab and virology experts
Solutions for Every Stage of Avian Influenza Research and Development
- High-titer, ready-to-ship viral stocks for immediate use
- Custom production of low-pathogenic and high-pathogenic strains tailored to your study needs
- Assay development and validation services for discovery, preclinical, and clinical programs
- Virus quantification assays (TCID50, PFU, ddPCR, qPCR)
- Reverse genetics services for safer strain engineering and targeted mutation studies
- Influenza-specific assays such as hemagglutination inhibition (HAI), neuraminidase inhibition (NAI), and microneutralization (MN)
Why Partner with Microbiologics?
Comprehensive Viral Solutions — Ready-to-ship and custom Avian Influenza viral stocks
Assay Development Excellence — Decades of expertise in assay design, optimization, and validation
Flexible CRO Services — Discovery through clinical development support
BSL-2 and BSL-3 Capabilities — Safe and scalable virology services for low- and high-pathogenic strains
Collaborative Approach — Personalized consultation, tailored solutions, responsive support
Proven Quality — ISO 13485:2016 certified BSL-2 and BSL-3 viral stock production
Ready to Advance Your Avian Influenza Research?
Connect with our virology experts for a personalized consultation today.